Correlative Investigation of Dynamic Contrast CT and Positron Emission Tomography with 18-Fluorodeoxy Glucose Standardized Uptake Value in Non-Small Cell Lung Cancer

DING Qi-yong,HUA Yan-qing,GUAN Yi-hui,ZHAO Jun,ZHU Feng,MAO Ding-biao,GE Xiao-jun,ZHANG Guo-zhen
DOI: https://doi.org/10.3760/j.issn:1005-1201.2005.11.003
2005-01-01
Abstract:Objective To explore the co rr elation of dynamic enhanced CT attenuation and 18-fluorodeoxy glucose(~ 18F-FDG) standardized uptake value (SUV) in non-small cell lung cancer (NSC LC). Methods Twenty-eight NSCLC patients and 13 patient s with benign nodules (28 male, 13 female; age range 15-79 years, median 57 years; the diameter range from 0.8-4.0 cm, mean 2.2 cm) were examined on Siemens biograph sensation 16 PET-CT with ~18F-FDG. Dynamic enhanced CT scan was performed on Siemens sensation 16 PET-CT or 16 slice CT in 23 patients and other 18 patients had the results of dynamic CT from other hospitals. The mean CT attenuation of ROI on precontrast and postcontrast multi-phase images, the maxium and average SUV of ~18F-FDG were respectively measured. The co rrelation between the peak attenuation(A_PA) and SUV was analyzed with pear son correlation coefficient test. Results The CT A_P A between NSCLC and benign nodules had no significance difference (t=1.37 4,P=0.189). The difference of maximum and average SUV between NSCLC a nd benignity were significant (t=-3.972,P0.001 t=-4.0 61,P0.001 respectively). No correlation was found among A_PA, maxim um SUV (7.23±4.38), and average SUV(4.93±3.53) (r=-0.040,P=0.83 9 r= 0.056,P=0.778). Conclusion There i s no correlation between A_PA and SUV in NSCLC. SUV is probably not suitab le for the evaluation of the effects of anti-angiogenesis therapy.
What problem does this paper attempt to address?